Effects of angiotensin II type 2 receptor overexpression on the growth of hepatocellular carcinoma cells in vitro and in vivo

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Du, Hongyan ^a   Liang, Zhibing ^a   Zhang, Yanling ^a   Jie, Feilong ^a   Li, Jinlong ^a   Fei, Yang ^a   Huang, Zhi ^a   Pei, Nana ^a   Wang, Suihai ^a   Li, Andrew ^b   Chen, Baihong ^a   Zhang, Yi ^c   Sumners, Colin ^c   Li, Ming ^a   Li, Hongwei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL PROLIFERATION; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ANGIOTENSIN, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84894277462     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083754     Document Type: Article

References (50)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. doi: 10.3322/caac.20107.
2. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, et al. (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005-1017. doi: 10.1016/j.cell.2009.04.021.
3. Ylä-Herttuala S (2012) Endgame: glybera finally recommended for approval as the first gene therapy drug in the European Union. Mol Ther 20: 1831-1832. doi: 10.1038/mt.2012.194.
4. Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J (2013) Gene therapy clinical trials worldwide to 2012 - an update. J Gene Med 15: 65-77. doi:10.1002/jgm.2698.
5. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, et al. (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251. (Pubitemid 23191415)
6. Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, et al. (2005) Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 26: 271-279. (Pubitemid 40253497)
7. Kanehira T, Tani T, Takagi T, Nakano Y, Howard EF, et al. (2005) Angiotensin II type 2 receptor gene deficiency attenuates susceptibility to tobacco-specific nitrosamine-induced lung tumorigenesis: involvement of transforming growth factor-beta-dependent cell growth attenuation. Cancer Res 65:7660-7665. (Pubitemid 41297239)
8. Ino K, Shibata K, Kajiyama H, Yamamoto E, Nagasaka T, et al. (2006) Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival. Br J Cancer 94:552-560. (Pubitemid 43289760)
9. Yoshiji H, Kuriyama S, Noguchi R, Yoshii J, Ikenaka Y et al. (2006) Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activities. Oncol Rep 15: 155-159.
10. Yoshiji H, Noguchi R, Kuriyama S, Yoshii J, Ikenaka Y (2005) Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice. Oncol Rep 13: 491-495.
11. Noguchi R, Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y et al. (2003) Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis. Clin Cancer Res 9: 6038-6045. (Pubitemid 38018091)
12. Qi Y, Li H, Shenoy V, Li Q, Wong F, et al. (2012) Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury. Exp Physiol 97: 89-101. doi: 10.1113/expphysiol.2011.060673.
13. Sun L, Wang W, Xiao W, Liang H, Yang Y, et al. (2012) Angiotensin II induces apoptosis in intestinal epithelial cells through the AT2 receptor, GATA-6 and the Bax pathway. Biochem Biophys Res Commun 424: 663-668. doi: 10.1016/j.bbrc.2012.07.003.
14. Wang X, Lu J, Khaidakov M, Mitra S, Ding Z, et al. (2012) Delineation of the effects of angiotensin type 1 and 2 receptors on HL-1 cardiomyocyte apoptosis. Apoptosis 17: 908-915. doi: 10.1007/s10495-012-0721-6.
15. Yan X, Price RL, Nakayama M, Ito K, Schuldt AJ, et al. (2003) Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice. Am J Physiol Heart Circ Physiol 285: H2179-H2187. doi: 10.1152/ajpheart.00361.2003. (Pubitemid 37305963)
16. Tejera N, Gómez-Garre D, Lázaro A, Gallego-Delgado J, Alonso C, et al. (2004) Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells. Am J Pathol 164: 1817-1826. (Pubitemid 38529784)
17. Horiuchi M, Akishita M, Dzau VJ (1998) Molecular and cellular mechanism of angiotensin II-mediated apoptosis. Endocr Res 24: 307-314. (Pubitemid 29016402)
18. Suzuki J, Iwai M, Nakagami H, Wu L, Chen R, et al. (2002) Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation 106: 847-853. doi: 10.1161/01.CIR.0000024103. 04821.86.
19. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, et al. (1995) The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95: 651-657. doi: 10.1172/JCI117710.
20. Li H, Qi Y, Li C, Braseth LN, Gao Y, et al. (2009) Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells. Mol Cancer Ther 8:3255-3265. doi: 10.1158/1535-7163.MCT-09-0237.
21. Pickel L, Matsuzuka T, Doi C, Ayuzawa R, Maurya DK, et al.(2010) Overexpression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells. Cancer Biol Ther 9: 277-285.
22. Li HW, Gao YX, Raizada MK, Sumners C (2005) Intronic enhancement of angiotensin II type 2 receptor transgene expression in vitro and in vivo. Biochem Biophys Res Commun 336: 29-35. (Pubitemid 41253398)
23. Li HW, Li J, Helm GA, Pan D (2005) Highly specific expression of luciferase gene in lungs of naïve nude mice directed by prostate-specific antigen promoter. Biochem Biophys Res Commun 334: 1287-1291. (Pubitemid 41074713)
24. Honigman A, Zeira E, Ohana P, Abramovitz R, Tavor E, et al. (2001) Imaging transgene expression in live animals. Mol Ther 4: 239-249. doi: 10.1006/mthe.2001.0437. (Pubitemid 32851288)
25. Wang S, Huang X, Li Y, Lao H, Zhang Y, et al. (2011) RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway. Hepatology. 53:1932-1942. doi: 10.1002/hep.24291.
26. Ma Y, Ma L, Guo Q, Zhang S (2010) Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients. J Exp Clin Cancer Res. 29:85. doi: 10.1186/1756-9966-29-85.
27. Fabregat I (2009) Dysregulation of apoptosis in hepatocellular carcinoma cells. World J Gastroenterol 15: 513-520. doi: 10.3748/wjg.15.513.
28. Revankar CM, Vines CM, Cimino DF, Prossnitz ER (2004) Arrestins block G protein coupled receptor-mediated apoptosis. J Biol Chem 279: 24578-24584. doi:10.1074/jbc.M402121200. (Pubitemid 38725324)
29. Tan NY, Li JM, Stocker R, Khachigian LM (2009) AngiotensinII-inducible smooth muscle cell apoptosis involves the angiotensin II type 2 receptor, GATA-6 activation, and Fasl-Fas engagement. Circ Res 105: 422-430. doi: 10.1161/CIRCRESAHA.109.203323.
30. D'Amore A, Black MJ, Thomas WG (2005) The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. Hypertension 46: 1347-1354. doi: 10.1161/01.HYP.0000193504.51489.cf. (Pubitemid 43189734)
31. Li H, Gao Y, Grobe JL, Raizada MK, Katovich MJ, et al. (2007) Potentiation of the antihypertensive action of losartan by peripheral overexpression of the ANG II type 2 receptor. Am J Physiol Heart Circ Physiol 292: H727-H735. doi: 10.1152/ajpheart.00938.2006.
32. Miura S, Karnik SS (2000) Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. EMBO J 19: 4026-4035. doi:10.1093/emboj/19.15. 4026. (Pubitemid 30608541)
33. Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M (2002) Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 294: 441-447. (Pubitemid 34694114)
34. Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, et al. (2005) Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin Cancer Res 11: 2686-2694. doi: 10.1158/1078-0432.CCR-04-1946. (Pubitemid 40569470)
35. Arrieta O, Guevara P, Escobar E, Garcia- Navarrete R, Pineda B, et al. (2005) Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br J Cancer 92: 1247-1252. doi:10.1038/sj.bjc.6602483. (Pubitemid 40604399)
36. Uemura H, Ishiguro H, Nagashima Y, Sasaki T, Nakaigawa N, et al. (2005) Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells. Mol Cancer Ther 4: 1699-1709. doi: 10.1158/1535-7163.MCT-04-0295. (Pubitemid 41685304)
37. Kawabata A, Baoum A, Ohta N, Jacquez S, Seo GM, et al. (2012) Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Res 72: 2057-2667. doi: 10.1158/0008-5472.CAN-11-3634.
38. Doi C, Egashira N, Kawabata A, Maurya DK, Ohta N, et al. (2010) Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice. BMC Cancer 10: 67. doi: 10.1186/1471-2407-10-67.
39. Takagi T, Nakano Y, Takekoshi S, Inagami T, Tamura M (2002) Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis. Carcinogenesis 23: 1235-1241. doi: 10.1093/carcin/23.7.1235. (Pubitemid 34814783)
40. Kanehira T, Tani T, Takagi T, Nakano Y, Howard EF, et al. (2005) Angiotensin II type 2 receptor gene deficiency attenuates susceptibility to tobacco-specific nitrosamine-induced lung tumorigenesis: involvement of transforming growth factor-beta-dependent cell growth attenuation. Cancer Res 65: 7660-7665. doi: 10.1158/0008-5472.CAN-05-0275. (Pubitemid 41297239)
41. Clere N, Corre I, Faure S, Guihot AL, Vessières E, et al. (2010) Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis. Int J Cancer 127:2279-2291.
42. Fujiyama S, Matsubara H, Nozawa Y, Maruyama K, Mori Y, et al. (2001) Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 88: 22-29. doi: 10.1161/01.RES.88.1.22. (Pubitemid 32064078)
43. Silvestre JS, Tamarat R, Senbonmatsu T, Icchiki T, Ebrahimian T, et al. (2002) Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ Res 90: 1072-1079. doi: 10.1161/01.RES.0000019892.41157.24. (Pubitemid 34627905)
44. Walther T, Menrad A, Orzechowski HD, Siemeister G, Paul M, et al. (2003) Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J 17: 2061-2067. doi:10.1096/fj.03-0129com. (Pubitemid 37392450)
45. Rizkalla B, Forbes JM, Cooper ME, Cao Z (2003) Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors. J Am Soc Nephrol 14: 3061-3071. doi:10.1097/01.ASN.0000099374.58607.C9. (Pubitemid 37509284)
46. Zhang X, Lassila M, Cooper ME, Cao Z (2004) Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors. Hypertension 43: 276-281. doi: 10.1161/01.HYP.0000113628.94574.0f. (Pubitemid 38174187)
47. Grieger JC, Samulski RJ (2012) Adeno-associated virus vectorology, manufacturing, and clinical applications. Methods Enzymol 507: 229-254. doi: 10.1016/B978-0-12-386509-0.00012-0.
48. Mitchell AM, Nicolson SC, Warischalk JK, Samulski RJ (2010) AAV's anatomy: roadmap for optimizing vectors for translational success. Curr Gene Ther 10: 319-340. doi: 10.2174/156652310793180706.
49. Mueller C, Flotte TR (2008) Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 15: 858-863. doi:10.1038/gt.2008.68. (Pubitemid 351712619)
50. Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, et al. (2011) Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 365: 2357-2365. doi: 10.1056/NEJMoa1108046.